Scholars@Duke

• Background
• 

  Education, Training, & Certifications

  • Ph.D., Temple University 2001
• 

  Previous Appointments & Affiliations

  • Professor of Biostatistics & Bioinformatics, Biostatistics & Bioinformatics, Basic Science Departments 2014 - 2020
  • Director, DCI Biostatistics, Biostatistics & Bioinformatics, Basic Science Departments 2014 - 2020
  • Adjunct Professor in the Department of Biostatistics & Bioinformatics, Biostatistics & Bioinformatics, Basic Science Departments 2013
• Recognition
• 

  Awards & Honors

  • Fellow. American Statistical Association. 2016
• Expertise
• 

  Subject Headings

  • Breast Neoplasms
  • Cancer Disparities
  • Case-Control Studies
  • Cohort Studies
  • Colorectal Neoplasms
  • Gastrointestinal Hormones
  • Gastrointestinal Tract
  • Health Disparities
  • Lung Neoplasms
  • Models, Statistical
  • Neoplasm Invasiveness
  • Prognosis
  • Socioeconomic Factors
  • Spatial analysis (Statistics)
  • Survival Analysis
  • Urogenital System
• Research
• 

  Selected Grants

  • Race-related differential RNA splicing: novel targets for precision oncology in non-small cell lung cancer awarded by National Institutes of Health 2020 - 2025
  • Optimizing the Management and Outcomes for Cancer Survivors Transitioning to Follow-up Care awarded by National Institutes of Health 2020 - 2025
  • Using Modifiable Risk Factors to Predict Inferior Care and Survival after Breast Cancer Diagnosis: A Novel Approach to Addressing Health Disparities awarded by National Institutes of Health 2019 - 2024
  • Duke University Program in Environmental Health awarded by National Institutes of Health 2013 - 2024
  • Beyond PD1: An immunotherapeutic strategy to stimulate and enable both T-cell and B-cell responses in immunosuppressive and non-mutated metastatic breast cancer awarded by Department of Defense 2020 - 2024
  • Comparison of Operative to Medical Endocrine Therapy (COMET) for Low Risk DCIS awarded by Alliance for Clinical Trials in Oncology Foundation 2016 - 2023
  • Preventing Inflammatory Breast Cancer Metastases by Interrupting Cellular Stress Signaling in Lymphatic Emboli and Circulating Tumor Cell Clusters awarded by Department of Defense 2020 - 2023
  • Targeting RNA splicing in race-related aggressive and lethal prostate cancer awarded by Prostate Cancer Foundation 2018 - 2022
  • Translational Research in Surgical Oncology awarded by National Institutes of Health 2002 - 2022
  • Race-related germline genetic variation and response to secondary hormonal therapy in metastatic castration-resistant prostate cancer awarded by Department of Defense 2019 - 2022
  • Epigenetic damage in women living in LA food-desert zip codes awarded by City of Hope 2017 - 2022
  • Combined breast MRI/biomarker strategies to identify aggressive biology awarded by City of Hope 2015 - 2022
  • Development of Cancer Survivorship Risk Models to Inform Pathways of Care awarded by Yale University 2021 - 2022
  • Race-related differential RNA splicing: novel targets for precision oncology in non-small cell lung cancer awarded by Department of Defense 2020 - 2022
  • Microscaled Proteogenomics for Cancer Clinical Trials awarded by Baylor College of Medicine 2017 - 2022
  • Intergovernmental Personnel Agreements (IPA) - Gu awarded by Durham Veterans Affairs Medical Center 2019 - 2021
  • Tension-Stat3-miR-mediated Metastasis awarded by City of Hope 2015 - 2021
  • Helicobacter pylori blood biomarker for gastric cancer risk in East Asia awarded by National Institutes of Health 2017 - 2020
  • Innovative Biomarker-Integrated Clinical Trial Design and Analysis awarded by University of North Carolina - Chapel Hill 2015 - 2020
  • Personal Service Agreement (PSA) Gu awarded by Institute for Medical Research, Inc. 2018 - 2019
  • Intergovernmental Personnel Agreements (IPA) Han awarded by Durham Veterans Affairs Medical Center 2019
  • IPA - Terry Hyslop awarded by Durham Veterans Affairs Medical Center 2017 - 2019
  • IPA - Lin Gu awarded by Durham Veterans Affairs Medical Center 2017 - 2018
  • The Mathematics of Breast Cancer Overtreatment: Improving Treatment Choice through Effective Communication of Personalized Cancer Risk awarded by National Institutes of Health 2016 - 2018
  • Joint Analysis of CALGB and LEA Study awarded by Alliance for Clinical Trials in Oncology Foundation 2015 - 2017
  • National Clinical Trials Network - Network Group Statistics and DMCs awarded by Mayo Clinic 2014 - 2017
  • Tension-Stat3-miR-mediated Metastasis awarded by City of Hope 2015 - 2017
  • Single cell analysis of intratumoral heterogeneity in parathyroid neoplasia awarded by National Institutes of Health 2015 - 2017
  • Small RNA Sequencing and prospective evaluation of HCC risk in HBV patients awarded by Thomas Jefferson University 2014 - 2016
  • Combined breast MRI/biomarker strategies to identify aggressive biology awarded by National Institutes of Health 2015
  • Tension-Stat3-miR-mediated metastasis awarded by University of California - San Francisco 2015
  • Structural Models of Breast Cancer Outcomes Disparities awarded by Susan G Komen for the Cure 2014 - 2015
  • Therapy-relevant stratification of breast cancer patients: Integrating pathology and biomarkers analysis awarded by Thomas Jefferson University 2014 - 2015
  • Occult tumor burden as a marker stratifying therapy to eliminate racial disparities in colon cancer awarded by Thomas Jefferson University 2014
  • Tumor MicroRNA Signatures as Prognostic Biomarkers of Colorectal Cancer awarded by Thomas Jefferson University 2014
  • Therapeutic vaccine bridging the gap in racial disparities in colorectal cancer awarded by Thomas Jefferson University 2014
• 

  External Relationships

  • City of Hope
  • Medical College of Wisconsin
  • Medical University of South Carolina
  • The University of North Carolina at Chapel Hill
  • University of California, San Francisco
  • University of South Carolina
  • VCU Massey Cancer Center
• Publications & Artistic Works
• 

  Selected Publications

  • Academic Articles

    • Plichta, Jennifer K., Samantha M. Thomas, Amanda R. Sergesketter, Rachel A. Greenup, Laura H. Rosenberger, Oluwadamilola M. Fayanju, Gretchen Kimmick, Jeremy Force, Terry Hyslop, and E Shelley Hwang. “A Novel Staging System for De Novo Metastatic Breast Cancer Refines Prognostic Estimates.” Ann Surg 275, no. 4 (April 1, 2022): 784–92. https://doi.org/10.1097/SLA.0000000000004231.
       Full Text  Link to Item
    • Magbanua, Mark Jesus M., Laura H. Hendrix, Terry Hyslop, William T. Barry, Eric P. Winer, Clifford Hudis, Deborah Toppmeyer, et al. “Serial Analysis of Circulating Tumor Cells in Metastatic Breast Cancer Receiving First-Line Chemotherapy.” J Natl Cancer Inst 113, no. 4 (April 6, 2021): 443–52. https://doi.org/10.1093/jnci/djaa113.
       Full Text  Link to Item
    • Grimm, Lars J., Benjamin Neely, Rui Hou, Vignesh Selvakumaran, Jay A. Baker, Sora C. Yoon, Sujata V. Ghate, et al. “Mixed-Methods Study to Predict Upstaging of DCIS to Invasive Disease on Mammography.” Ajr Am J Roentgenol 216, no. 4 (April 2021): 903–11. https://doi.org/10.2214/AJR.20.23679.
       Full Text  Link to Item
    • Larsen, Alexandra, Viktoria Kolpacoff, Kara McCormack, Victoria Seewaldt, and Terry Hyslop. “Using Latent Class Modeling to Jointly Characterize Economic Stress and Multipollutant Exposure.” Cancer Epidemiol Biomarkers Prev 29, no. 10 (October 2020): 1940–48. https://doi.org/10.1158/1055-9965.EPI-19-1365.
       Full Text  Link to Item
    • Varga, Matthew G., Julia Butt, William J. Blot, Loïc Le Marchand, Christopher A. Haiman, Yu Chen, Sylvia Wassertheil-Smoller, et al. “Racial Differences in Helicobacter pylori CagA Sero-prevalence in a Consortium of Adult Cohorts in the United States.” Cancer Epidemiol Biomarkers Prev 29, no. 10 (October 2020): 2084–92. https://doi.org/10.1158/1055-9965.EPI-20-0525.
       Full Text  Link to Item
    • Crosby, Erika J., Chaitanya R. Acharya, Anthony-Fayez Haddad, Christopher A. Rabiola, Gangjun Lei, Jun-Ping Wei, Xiao-Yi Yang, et al. “Stimulation of Oncogene-Specific Tumor-Infiltrating T Cells through Combined Vaccine and αPD-1 Enable Sustained Antitumor Responses against Established HER2 Breast Cancer.” Clin Cancer Res 26, no. 17 (September 1, 2020): 4670–81. https://doi.org/10.1158/1078-0432.CCR-20-0389.
       Full Text  Link to Item
    • Ong, Cecilia T., Yi Ren, Samantha M. Thomas, Ilona Stashko, Terry Hyslop, Gretchen Kimmick, Rachel C. Blitzblau, E Shelley Hwang, Lars J. Grimm, and Rachel A. Greenup. “Overall health at diagnosis predicts the risk of complications within the first year after breast cancer diagnosis.” Breast Cancer Res Treat 182, no. 2 (July 2020): 439–49. https://doi.org/10.1007/s10549-020-05700-8.
       Full Text  Link to Item
    • Hwang, E Shelley, Terry Hyslop, Laura H. Hendrix, Stephanie Duong, Isabelle Bedrosian, Elissa Price, Abigail Caudle, et al. “Phase II Single-Arm Study of Preoperative Letrozole for Estrogen Receptor-Positive Postmenopausal Ductal Carcinoma In Situ: CALGB 40903 (Alliance).” J Clin Oncol 38, no. 12 (April 20, 2020): 1284–92. https://doi.org/10.1200/JCO.19.00510.
       Full Text  Link to Item
    • Fayanju, Oluwadamilola M., Yi Ren, Samantha M. Thomas, Rachel A. Greenup, Terry Hyslop, E Shelley Hwang, and John H. Stewart. “A Case-Control Study Examining Disparities in Clinical Trial Participation Among Breast Surgical Oncology Patients.” Jnci Cancer Spectr 4, no. 2 (April 2020): pkz103. https://doi.org/10.1093/jncics/pkz103.
       Full Text  Link to Item
    • Barrett, Nadine J., Elisa M. Rodriguez, Ronaldo Iachan, Terry Hyslop, Kearston L. Ingraham, Gem M. Le, Kelly Martin, et al. “Factors associated with biomedical research participation within community-based samples across 3 National Cancer Institute-designated cancer centers.” Cancer 126, no. 5 (March 1, 2020): 1077–89. https://doi.org/10.1002/cncr.32487.
       Full Text  Link to Item
    • Lieberman, David, Brian A. Sullivan, Elizabeth R. Hauser, Xuejun Qin, Laura W. Musselwhite, Meghan C. O’Leary, Thomas S. Redding, et al. “Baseline Colonoscopy Findings Associated With 10-Year Outcomes in a Screening Cohort Undergoing Colonoscopy Surveillance.” Gastroenterology 158, no. 4 (March 2020): 862-874.e8. https://doi.org/10.1053/j.gastro.2019.07.052.
       Full Text  Link to Item
    • Mundy, Lily R., Laura H. Rosenberger, Christel N. Rushing, Dunya Atisha, Andrea L. Pusic, Scott T. Hollenbeck, Terry Hyslop, and E Shelley Hwang. “The Evolution of Breast Satisfaction and Well-Being after Breast Cancer: A Propensity-Matched Comparison to the Norm.” Plast Reconstr Surg 145, no. 3 (March 2020): 595–604. https://doi.org/10.1097/PRS.0000000000006535.
       Full Text  Link to Item
    • Fayanju, Oluwadamilola M., Yi Ren, Gita Suneja, Samantha M. Thomas, Rachel A. Greenup, Jennifer K. Plichta, Laura H. Rosenberger, Jeremy Force, Terry Hyslop, and E Shelley Hwang. “Nodal Response to Neoadjuvant Chemotherapy Predicts Receipt of Radiation Therapy After Breast Cancer Diagnosis.” Int J Radiat Oncol Biol Phys 106, no. 2 (February 1, 2020): 377–89. https://doi.org/10.1016/j.ijrobp.2019.10.039.
       Full Text  Open Access Copy  Link to Item
    • Fayanju, Oluwadamilola M., Yi Ren, Rachel A. Greenup, Jennifer K. Plichta, Laura H. Rosenberger, Jeremy Force, Gita Suneja, et al. “Extent of axillary surgery in inflammatory breast cancer: a survival analysis of 3500 patients.” Breast Cancer Res Treat 180, no. 1 (February 2020): 207–17. https://doi.org/10.1007/s10549-020-05529-1.
       Full Text  Link to Item
    • Satpathy, Shankha, Eric J. Jaehnig, Karsten Krug, Beom-Jun Kim, Alexander B. Saltzman, Doug W. Chan, Kimberly R. Holloway, et al. “Microscaled proteogenomic methods for precision oncology.” Nat Commun 11, no. 1 (January 27, 2020): 532. https://doi.org/10.1038/s41467-020-14381-2.
       Full Text  Link to Item
    • Plichta, Jennifer K., Yi Ren, Samantha M. Thomas, Rachel A. Greenup, Oluwadamilola M. Fayanju, Laura H. Rosenberger, Terry Hyslop, and E Shelley Hwang. “Implications for Breast Cancer Restaging Based on the 8th Edition AJCC Staging Manual.” Ann Surg 271, no. 1 (January 2020): 169–76. https://doi.org/10.1097/SLA.0000000000003071.
       Full Text  Link to Item
    • Musselwhite, Laura W., Thomas S. Redding, Kellie J. Sims, Meghan C. O’Leary, Elizabeth R. Hauser, Terry Hyslop, Ziad F. Gellad, Brian A. Sullivan, David Lieberman, and Dawn Provenzale. “Advanced neoplasia in Veterans at screening colonoscopy using the National Cancer Institute Risk Assessment Tool.” Bmc Cancer 19, no. 1 (November 12, 2019): 1097. https://doi.org/10.1186/s12885-019-6204-1.
       Full Text  Link to Item
    • Zambeli-Ljepović, Alan, Frances Wang, Michaela A. Dinan, Terry Hyslop, Michael T. Stang, Sanziana A. Roman, Julie A. Sosa, and Randall P. Scheri. “Extent of surgery for low-risk thyroid cancer in the elderly: Equipoise in survival but not in short-term outcomes.” Surgery 166, no. 5 (November 2019): 895–900. https://doi.org/10.1016/j.surg.2019.05.035.
       Full Text  Link to Item
    • Zambeli-Ljepović, Alan, Frances Wang, Michaela A. Dinan, Terry Hyslop, Sanziana A. Roman, Julie Ann Sosa, and Randall P. Scheri. “Low-Risk Thyroid Cancer in Elderly: Total Thyroidectomy/RAI Predominates but Lacks Survival Advantage.” J Surg Res 243 (November 2019): 189–97. https://doi.org/10.1016/j.jss.2019.05.029.
       Full Text  Link to Item
    • Cocce, Kimberly J., Jeff S. Jasper, Taylor K. Desautels, Logan Everett, Suzanne Wardell, Thomas Westerling, Robert Baldi, et al. “The Lineage Determining Factor GRHL2 Collaborates with FOXA1 to Establish a Targetable Pathway in Endocrine Therapy-Resistant Breast Cancer.” Cell Rep 29, no. 4 (October 22, 2019): 889-903.e10. https://doi.org/10.1016/j.celrep.2019.09.032.
       Full Text  Link to Item
    • Plichta, Jennifer K., Samantha M. Thomas, Amanda R. Sergesketter, Rachel A. Greenup, Oluwadamilola M. Fayanju, Laura H. Rosenberger, Nina Tamirisa, Terry Hyslop, and E Shelley Hwang. “Clinical and pathological stage discordance among 433,514 breast cancer patients.” Am J Surg 218, no. 4 (October 2019): 669–76. https://doi.org/10.1016/j.amjsurg.2019.07.016.
       Full Text  Open Access Copy  Link to Item
    • Ryser, Marc D., Donald L. Weaver, Fengmin Zhao, Mathias Worni, Lars J. Grimm, Roman Gulati, Ruth Etzioni, Terry Hyslop, Sandra J. Lee, and E Shelley Hwang. “Cancer Outcomes in DCIS Patients Without Locoregional Treatment.” J Natl Cancer Inst 111, no. 9 (September 1, 2019): 952–60. https://doi.org/10.1093/jnci/djy220.
       Full Text  Link to Item
    • Sergesketter, Amanda R., Samantha M. Thomas, Oluwadamilola M. Fayanju, Carolyn S. Menendez, Laura H. Rosenberger, Rachel A. Greenup, Terry Hyslop, Edgardo R. Parrilla Castellar, E Shelley Hwang, and Jennifer K. Plichta. “The Influence of Age on the Histopathology and Prognosis of Atypical Breast Lesions.” J Surg Res 241 (September 2019): 188–98. https://doi.org/10.1016/j.jss.2019.03.047.
       Full Text  Open Access Copy  Link to Item
    • Martín, M., S. Loibl, T. Hyslop, J. De la Haba-Rodríguez, B. Aktas, C. T. Cirrincione, K. Mehta, et al. “Evaluating the addition of bevacizumab to endocrine therapy as first-line treatment for hormone receptor-positive metastatic breast cancer: a pooled analysis from the LEA (GEICAM/2006-11_GBG51) and CALGB 40503 (Alliance) trials.” Eur J Cancer 117 (August 2019): 91–98. https://doi.org/10.1016/j.ejca.2019.06.002.
       Full Text  Link to Item
    • Greenup, Rachel A., Christel Rushing, Laura Fish, Brittany M. Campbell, Lisa Tolnitch, Terry Hyslop, Jeffrey Peppercorn, et al. “Financial Costs and Burden Related to Decisions for Breast Cancer Surgery.” J Oncol Pract 15, no. 8 (August 2019): e666–76. https://doi.org/10.1200/JOP.18.00796.
       Full Text  Link to Item
    • Ryser, Marc D., Laura H. Hendrix, Mathias Worni, Yiling Liu, Terry Hyslop, and E Shelley Hwang. “Incidence of Ductal Carcinoma In Situ in the United States, 2000-2014.” Cancer Epidemiol Biomarkers Prev 28, no. 8 (August 2019): 1316–23. https://doi.org/10.1158/1055-9965.EPI-18-1262.
       Full Text  Link to Item
    • Tamirisa, Nina, Hannah V. Williamson, Samantha M. Thomas, Kelly E. Westbrook, Rachel A. Greenup, Jennifer K. Plichta, Laura H. Rosenberger, Terry Hyslop, Eun-Sil Shelley Hwang, and Oluwadamilola M. Fayanju. “The impact of chemotherapy sequence on survival in node-positive invasive lobular carcinoma.” J Surg Oncol 120, no. 2 (August 2019): 132–41. https://doi.org/10.1002/jso.25492.
       Full Text  Open Access Copy  Link to Item
    • Grimm, Lars J., Matthew M. Miller, Samantha M. Thomas, Yiling Liu, Joseph Y. Lo, E Shelley Hwang, Terry Hyslop, and Marc D. Ryser. “Growth Dynamics of Mammographic Calcifications: Differentiating Ductal Carcinoma in Situ from Benign Breast Disease.” Radiology 292, no. 1 (July 2019): 77–83. https://doi.org/10.1148/radiol.2019182599.
       Full Text  Link to Item
    • Crosby, Erika J., William Gwin, Kimberly Blackwell, Paul K. Marcom, Serena Chang, Holden T. Maecker, Gloria Broadwater, et al. “Vaccine-Induced Memory CD8+ T Cells Provide Clinical Benefit in HER2 Expressing Breast Cancer: A Mouse to Human Translational Study.” Clin Cancer Res 25, no. 9 (May 1, 2019): 2725–36. https://doi.org/10.1158/1078-0432.CCR-18-3102.
       Full Text  Open Access Copy  Link to Item
    • Snook, Adam E., Trevor R. Baybutt, Bo Xiang, Tara S. Abraham, John C. Flickinger, Terry Hyslop, Tingting Zhan, Walter K. Kraft, Takami Sato, and Scott A. Waldman. “Split tolerance permits safe Ad5-GUCY2C-PADRE vaccine-induced T-cell responses in colon cancer patients.” J Immunother Cancer 7, no. 1 (April 23, 2019): 104. https://doi.org/10.1186/s40425-019-0576-2.
       Full Text  Link to Item
    • Hwang, E Shelley, Terry Hyslop, Thomas Lynch, Elizabeth Frank, Donna Pinto, Desiree Basila, Deborah Collyar, et al. “The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS).” Bmj Open 9, no. 3 (March 12, 2019): e026797. https://doi.org/10.1136/bmjopen-2018-026797.
       Full Text  Link to Item
    • Lane, Whitney O., Samantha M. Thomas, Rachel C. Blitzblau, Jennifer K. Plichta, Laura H. Rosenberger, Oluwadamilola M. Fayanju, Terry Hyslop, E Shelley Hwang, and Rachel A. Greenup. “Surgical Resection of the Primary Tumor in Women With De Novo Stage IV Breast Cancer: Contemporary Practice Patterns and Survival Analysis.” Ann Surg 269, no. 3 (March 2019): 537–44. https://doi.org/10.1097/SLA.0000000000002621.
       Full Text  Link to Item
    • Mremi, Alex, Gloria Broadwater, Kahima Jackson, Patrick Amsi, Cosmas Mbulwa, Terry Hyslop, Cecilia Ong, and Allison Hall. “Breast cancer in Tanzanian, black American, and white American women: An assessment of prognostic and predictive features, including tumor infiltrating lymphocytes.” Plos One 14, no. 11 (2019): e0224760. https://doi.org/10.1371/journal.pone.0224760.
       Full Text  Link to Item
    • Tran, Thai H., Fransiscus E. Utama, Takahiro Sato, Amy R. Peck, John F. Langenheim, Sameer S. Udhane, Yunguang Sun, et al. “Loss of Nuclear Localized Parathyroid Hormone-Related Protein in Primary Breast Cancer Predicts Poor Clinical Outcome and Correlates with Suppressed Stat5 Signaling.” Clin Cancer Res 24, no. 24 (December 15, 2018): 6355–66. https://doi.org/10.1158/1078-0432.CCR-17-3280.
       Full Text  Link to Item
    • Tanioka, Maki, Cheng Fan, Joel S. Parker, Katherine A. Hoadley, Zhiyuan Hu, Yan Li, Terry M. Hyslop, et al. “Integrated Analysis of RNA and DNA from the Phase III Trial CALGB 40601 Identifies Predictors of Response to Trastuzumab-Based Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer.” Clin Cancer Res 24, no. 21 (November 1, 2018): 5292–5304. https://doi.org/10.1158/1078-0432.CCR-17-3431.
       Full Text  Link to Item
    • Fayanju, Oluwadamilola M., Yi Ren, Samantha M. Thomas, Rachel A. Greenup, Jennifer K. Plichta, Laura H. Rosenberger, Nina Tamirisa, et al. “The Clinical Significance of Breast-only and Node-only Pathologic Complete Response (pCR) After Neoadjuvant Chemotherapy (NACT): A Review of 20,000 Breast Cancer Patients in the National Cancer Data Base (NCDB).” Ann Surg 268, no. 4 (October 2018): 591–601. https://doi.org/10.1097/SLA.0000000000002953.
       Full Text  Link to Item
    • Force, Jeremy, Lynn J. Howie, Sara E. Abbott, Rex Bentley, P Kelly Marcom, Gretchen Kimmick, Kelly Westbrook, et al. “Early Stage HER2-Positive Breast Cancers Not Achieving a pCR From Neoadjuvant Trastuzumab- or Pertuzumab-Based Regimens Have an Immunosuppressive Phenotype.” Clin Breast Cancer 18, no. 5 (October 2018): 410–17. https://doi.org/10.1016/j.clbc.2018.02.010.
       Full Text  Link to Item
    • Park, Tristen S., Samantha M. Thomas, Laura H. Rosenberger, Oluwadamilola M. Fayanju, Jennifer K. Plichta, Rachel C. Blitzblau, Cecilia T. Ong, Terry Hyslop, E Shelley Hwang, and Rachel A. Greenup. “The Association of Extent of Axillary Surgery and Survival in Women with N2-3 Invasive Breast Cancer.” Ann Surg Oncol 25, no. 10 (October 2018): 3019–29. https://doi.org/10.1245/s10434-018-6587-2.
       Full Text  Link to Item
    • Chervoneva, Inna, Boris Freydin, Terry Hyslop, and Scott A. Waldman. “Modeling qRT-PCR dynamics with application to cancer biomarker quantification.” Stat Methods Med Res 27, no. 9 (September 2018): 2581–95. https://doi.org/10.1177/0962280216683204.
       Full Text  Link to Item
    • Ong, Cecilia T., Brittany M. Campbell, Samantha M. Thomas, Rachel A. Greenup, Jennifer K. Plichta, Laura H. Rosenberger, Jeremy Force, et al. “Metaplastic Breast Cancer Treatment and Outcomes in 2500 Patients: A Retrospective Analysis of a National Oncology Database.” Ann Surg Oncol 25, no. 8 (August 2018): 2249–60. https://doi.org/10.1245/s10434-018-6533-3.
       Full Text  Link to Item
    • Freedman, Jennifer A., Yanru Wang, Xuechan Li, Hongliang Liu, Patricia G. Moorman, Daniel J. George, Norman H. Lee, Terry Hyslop, Qingyi Wei, and Steven R. Patierno. “Single-nucleotide polymorphisms of stemness genes predicted to regulate RNA splicing, microRNA and oncogenic signaling are associated with prostate cancer survival.” Carcinogenesis 39, no. 7 (July 3, 2018): 879–88. https://doi.org/10.1093/carcin/bgy062.
       Full Text  Open Access Copy  Link to Item
    • Kaji, Amy H., Alfred W. Rademaker, and Terry Hyslop. “Tips for Analyzing Large Data Sets From the JAMA Surgery Statistical Editors.” Jama Surg 153, no. 6 (June 1, 2018): 508–9. https://doi.org/10.1001/jamasurg.2018.0647.
       Full Text  Link to Item
    • Adam, Mohamed A., Samantha Thomas, Linda Youngwirth, Terry Hyslop, Shelby D. Reed, Randall P. Scheri, Sanziana A. Roman, and Julie A. Sosa. “Reply to: "Surgeon Volume Threshold for Total Thyroidectomy".” Ann Surg 267, no. 4 (April 2018): e78–79. https://doi.org/10.1097/SLA.0000000000002161.
       Full Text  Link to Item
    • Magbanua, Mark Jesus M., Hope S. Rugo, Denise M. Wolf, Louai Hauranieh, Ritu Roy, Praveen Pendyala, Eduardo V. Sosa, et al. “Expanded Genomic Profiling of Circulating Tumor Cells in Metastatic Breast Cancer Patients to Assess Biomarker Status and Biology Over Time (CALGB 40502 and CALGB 40503, Alliance).” Clin Cancer Res 24, no. 6 (March 15, 2018): 1486–99. https://doi.org/10.1158/1078-0432.CCR-17-2312.
       Full Text  Link to Item
    • Grimm, Lars J., Marc D. Ryser, and Terry Hyslop. “Role of Preoperative Variables in Reducing the Rate of Occult Invasive Disease for Women Considering Active Surveillance for Ductal Carcinoma In Situ.” Jama Surg 153, no. 3 (March 1, 2018): 290–91. https://doi.org/10.1001/jamasurg.2017.5566.
       Full Text  Link to Item
    • Greenup, Rachel A., Samilia Obeng-Gyasi, Samantha Thomas, K. Houck, Whitney O. Lane, Rachel C. Blitzblau, Terry Hyslop, and E Shelley Hwang. “The Effect of Hospital Volume on Breast Cancer Mortality.” Ann Surg 267, no. 2 (February 2018): 375–81. https://doi.org/10.1097/SLA.0000000000002095.
       Full Text  Link to Item
    • Xu, Yinghui, Yanru Wang, Hongliang Liu, Qiong Shi, Dakai Zhu, Christopher I. Amos, Shenying Fang, et al. “Genetic variants in the metzincin metallopeptidase family genes predict melanoma survival.” Mol Carcinog 57, no. 1 (January 2018): 22–31. https://doi.org/10.1002/mc.22716.
       Full Text  Open Access Copy  Link to Item
    • Ong, Cecilia T., Samantha M. Thomas, Rachel C. Blitzblau, Oluwadamilola M. Fayanju, Tristen S. Park, Jennifer K. Plichta, Laura H. Rosenberger, Terry Hyslop, E. Shelley Hwang, and Rachel A. Greenup. “Patient Age and Tumor Subtype Predict the Extent of Axillary Surgery Among Breast Cancer Patients Eligible for the American College of Surgeons Oncology Group Trial Z0011.” Ann Surg Oncol 24, no. 12 (November 2017): 3559–66. https://doi.org/10.1245/s10434-017-6075-0.
       Full Text  Link to Item
    • Li, Peng, Evan Wuthrick, Jeff A. Rappaport, Crystal Kraft, Jieru E. Lin, Glen Marszalowicz, Adam E. Snook, Tingting Zhan, Terry M. Hyslop, and Scott A. Waldman. “GUCY2C Signaling Opposes the Acute Radiation-Induced GI Syndrome.” Cancer Res 77, no. 18 (September 15, 2017): 5095–5106. https://doi.org/10.1158/0008-5472.CAN-17-0859.
       Full Text  Link to Item
    • Adam, Mohamed Abdelgadir, Samantha Thomas, Sanziana A. Roman, Terry Hyslop, and Julie A. Sosa. “Rethinking the Current American Joint Committee on Cancer TNM Staging System for Medullary Thyroid Cancer.” Jama Surg 152, no. 9 (September 1, 2017): 869–76. https://doi.org/10.1001/jamasurg.2017.1665.
       Full Text  Link to Item
    • Liu, Shun, Yanru Wang, William Xue, Hongliang Liu, Yinghui Xu, Qiong Shi, Wenting Wu, et al. “Genetic variants in the genes encoding rho GTPases and related regulators predict cutaneous melanoma-specific survival.” Int J Cancer 141, no. 4 (August 15, 2017): 721–30. https://doi.org/10.1002/ijc.30785.
       Full Text  Link to Item
    • Wang, Yanru, Jennifer A. Freedman, Hongliang Liu, Patricia G. Moorman, Terry Hyslop, Daniel J. George, Norman H. Lee, Steven R. Patierno, and Qingyi Wei. “Associations between RNA splicing regulatory variants of stemness-related genes and racial disparities in susceptibility to prostate cancer.” Int J Cancer 141, no. 4 (August 15, 2017): 731–43. https://doi.org/10.1002/ijc.30787.
       Full Text  Link to Item
    • Anand, Sarah, Samantha Thomas, Terry Hyslop, Janet Adcock, Kelly Corbet, Cristina Gasparetto, Richard Lopez, et al. “Transplantation of Ex Vivo Expanded Umbilical Cord Blood (NiCord) Decreases Early Infection and Hospitalization.” Biol Blood Marrow Transplant 23, no. 7 (July 2017): 1151–57. https://doi.org/10.1016/j.bbmt.2017.04.001.
       Full Text  Link to Item
    • Cheng, Qing, Xuechan Li, Chaitanya R. Acharya, Terry Hyslop, and Julie Ann Sosa. “A novel integrative risk index of papillary thyroid cancer progression combining genomic alterations and clinical factors.” Oncotarget 8, no. 10 (March 7, 2017): 16690–703. https://doi.org/10.18632/oncotarget.15128.
       Full Text  Link to Item
    • Adam, Mohamed Abdelgadir, Samantha Thomas, Linda Youngwirth, Terry Hyslop, Shelby D. Reed, Randall P. Scheri, Sanziana A. Roman, and Julie A. Sosa. “Is There a Minimum Number of Thyroidectomies a Surgeon Should Perform to Optimize Patient Outcomes?” Ann Surg 265, no. 2 (February 2017): 402–7. https://doi.org/10.1097/SLA.0000000000001688.
       Full Text  Link to Item
    • Adam, Mohamed Abdelgadir, Samantha Thomas, Terry Hyslop, Randall P. Scheri, Sanziana A. Roman, and Julie A. Sosa. “Exploring the Relationship Between Patient Age and Cancer-Specific Survival in Papillary Thyroid Cancer: Rethinking Current Staging Systems.” J Clin Oncol 34, no. 36 (December 20, 2016): 4415–20. https://doi.org/10.1200/JCO.2016.68.9372.
       Full Text  Link to Item
    • Hwang, E Shelley, and Terry Hyslop. “Reply to J. Heil et al.” J Clin Oncol 34, no. 34 (December 2016): 4192. https://doi.org/10.1200/JCO.2016.69.1121.
       Full Text  Link to Item
    • Snook, Adam E., Trevor R. Baybutt, Terry Hyslop, and Scott A. Waldman. “Preclinical Evaluation of a Replication-Deficient Recombinant Adenovirus Serotype 5 Vaccine Expressing Guanylate Cyclase C and the PADRE T-helper Epitope.” Hum Gene Ther Methods 27, no. 6 (December 2016): 238–50. https://doi.org/10.1089/hgtb.2016.114.
       Full Text  Link to Item
    • Kim, Edward, Michaela Dinan, Km Monirul Islam, Ancilla Fernandes, Lee Schwartzberg, Elisabeth Croft, Julie Brahmer, et al. “PS01.61: Registry for the EVolution Of LUng Cancer Therapy Implementation and Outcomes Now (REVOLUTION): Registry Study in Progress: Topic: Medical Oncology.” J Thorac Oncol 11, no. 11S (November 2016): S308–9. https://doi.org/10.1016/j.jtho.2016.09.096.
       Full Text  Link to Item
    • Sung, Anthony D., Julia A. M. Sung, Samantha Thomas, Terry Hyslop, Cristina Gasparetto, Gwynn Long, David Rizzieri, et al. “Universal Mask Usage for Reduction of Respiratory Viral Infections After Stem Cell Transplant: A Prospective Trial.” Clin Infect Dis 63, no. 8 (October 15, 2016): 999–1006. https://doi.org/10.1093/cid/ciw451.
       Full Text  Link to Item
    • Peck, Amy R., Melanie A. Girondo, Chengbao Liu, Albert J. Kovatich, Jeffrey A. Hooke, Craig D. Shriver, Hai Hu, et al. “Validation of tumor protein marker quantification by two independent automated immunofluorescence image analysis platforms.” Mod Pathol 29, no. 10 (October 2016): 1143–54. https://doi.org/10.1038/modpathol.2016.112.
       Full Text  Link to Item
    • Robinson, Timothy J., Samantha Thomas, Michaela A. Dinan, Sanziana Roman, Julie Ann Sosa, and Terry Hyslop. “How Many Lymph Nodes Are Enough? Assessing the Adequacy of Lymph Node Yield for Papillary Thyroid Cancer.” J Clin Oncol 34, no. 28 (October 1, 2016): 3434–39. https://doi.org/10.1200/JCO.2016.67.6437.
       Full Text  Link to Item
    • Lai, Yinzhi, Chun Wang, Jesse M. Civan, Juan P. Palazzo, Zhong Ye, Terry Hyslop, Jianqing Lin, et al. “Effects of Cancer Stage and Treatment Differences on Racial Disparities in Survival From Colon Cancer: A United States Population-Based Study.” Gastroenterology 150, no. 5 (May 2016): 1135–46. https://doi.org/10.1053/j.gastro.2016.01.030.
       Full Text  Link to Item
    • Goodman, C. R., T. Sato, A. R. Peck, M. A. Girondo, N. Yang, C. Liu, A. F. Yanac, et al. “Steroid induction of therapy-resistant cytokeratin-5-positive cells in estrogen receptor-positive breast cancer through a BCL6-dependent mechanism.” Oncogene 35, no. 11 (March 17, 2016): 1373–85. https://doi.org/10.1038/onc.2015.193.
       Full Text  Link to Item
    • Adam, Mohamed Abdelgadir, Samantha Thomas, Linda Youngwirth, Terry Hyslop, Shelby D. Reed, Randall P. Scheri, Sanziana A. Roman, and Julie A. Sosa. “Is There a Minimum Number of Thyroidectomies a Surgeon Should Perform to Optimize Patient Outcomes?” Ann Surg, March 8, 2016. https://doi.org/10.1097/SLA.0000000000001688.
       Full Text  Link to Item
    • Palumbo, Aimee, Yvonne Michael, and Terry Hyslop. “Latent class model characterization of neighborhood socioeconomic status.” Cancer Causes Control 27, no. 3 (March 2016): 445–52. https://doi.org/10.1007/s10552-015-0711-4.
       Full Text  Link to Item
    • Lin, Jieru E., Francheska Colon-Gonzalez, Erik Blomain, Gilbert W. Kim, Amanda Aing, Brian Stoecker, Justin Rock, et al. “Obesity-Induced Colorectal Cancer Is Driven by Caloric Silencing of the Guanylin-GUCY2C Paracrine Signaling Axis.” Cancer Res 76, no. 2 (January 15, 2016): 339–46. https://doi.org/10.1158/0008-5472.CAN-15-1467-T.
       Full Text  Link to Item
    • He, Kevin, Yanming Li, Ji Zhu, Hongliang Liu, Jeffrey E. Lee, Christopher I. Amos, Terry Hyslop, et al. “Component-wise gradient boosting and false discovery control in survival analysis with high-dimensional covariates.” Bioinformatics 32, no. 1 (January 1, 2016): 50–57. https://doi.org/10.1093/bioinformatics/btv517.
       Full Text  Open Access Copy  Link to Item
    • Mu, Zhaomei, Chun Wang, Zhong Ye, Laura Austin, Jesse Civan, Terry Hyslop, Juan P. Palazzo, et al. “Prospective assessment of the prognostic value of circulating tumor cells and their clusters in patients with advanced-stage breast cancer.” Breast Cancer Res Treat 154, no. 3 (December 2015): 563–71. https://doi.org/10.1007/s10549-015-3636-4.
       Full Text  Link to Item
    • Adam, Mohamed Abdelgadir, John Pura, Paolo Goffredo, Michaela A. Dinan, Shelby D. Reed, Randall P. Scheri, Terry Hyslop, Sanziana A. Roman, and Julie A. Sosa. “Presence and Number of Lymph Node Metastases Are Associated With Compromised Survival for Patients Younger Than Age 45 Years With Papillary Thyroid Cancer.” J Clin Oncol 33, no. 21 (July 20, 2015): 2370–75. https://doi.org/10.1200/JCO.2014.59.8391.
       Full Text  Link to Item
    • Showalter, Timothy N., Sarah E. Hegarty, Carol Rabinowitz, Vittorio Maio, Terry Hyslop, Adam P. Dicker, and Daniel Z. Louis. “Assessing adverse events of postprostatectomy radiation therapy for prostate cancer: evaluation of outcomes in the Regione Emilia-Romagna, Italy.” Int J Radiat Oncol Biol Phys 91, no. 4 (March 15, 2015): 752–59. https://doi.org/10.1016/j.ijrobp.2014.11.038.
       Full Text  Link to Item
    • Adam, M. A., J. Pura, P. Goffredo, M. A. Dinan, T. Hyslop, S. D. Reed, R. P. Scheri, S. A. Roman, and J. A. Sosa. “Impact of extent of surgery on survival for papillary thyroid cancer patients younger than 45 years.” Journal of Clinical Endocrinology and Metabolism 100, no. 1 (2015): 115–21. https://doi.org/10.1210/jc.20143039.
       Full Text
    • Adam, Mohamed Abdelgadir, John Pura, Paolo Goffredo, Michaela A. Dinan, Terry Hyslop, Shelby D. Reed, Randall P. Scheri, Sanziana A. Roman, and Julie A. Sosa. “Impact of extent of surgery on survival for papillary thyroid cancer patients younger than 45 years.” J Clin Endocrinol Metab 100, no. 1 (January 2015): 115–21. https://doi.org/10.1210/jc.2014-3039.
       Full Text  Link to Item
    • Hegarty, Sarah E., Terry Hyslop, Adam P. Dicker, and Timothy N. Showalter. “Radiation therapy after radical prostatectomy for prostate cancer: evaluation of complications and influence of radiation timing on outcomes in a large, population-based cohort.” Plos One 10, no. 2 (2015): e0118430. https://doi.org/10.1371/journal.pone.0118430.
       Full Text  Link to Item
    • Lin, J., A. Deng, J. Hoffman-Censits, G. Gibney, T. Hyslop, B. Miller, D. Kilpatrick, S. Jabbour, and W. Kevin Kelly. “An open label randomized phase II study of pasireotide with or without everolimus in castrate-resistant chemotherapy-naïve prostate cancer patients.” Cancer Treatment Communications 4 (January 1, 2015): 192–95. https://doi.org/10.1016/j.ctrc.2015.11.003.
       Full Text
    • Wang, Chun, Jesse Civan, Yinzhi Lai, Massimo Cristofanilli, Terry Hyslop, Juan P. Palazzo, Ronald E. Myers, et al. “Racial disparity in breast cancer survival: the impact of pre-treatment hematologic variables.” Cancer Causes Control 26, no. 1 (January 2015): 45–56. https://doi.org/10.1007/s10552-014-0481-4.
       Full Text  Link to Item
    • Wilson, Chantell, Jieru E. Lin, Peng Li, Adam E. Snook, Jianping Gong, Takahiro Sato, Chengbao Liu, et al. “The paracrine hormone for the GUCY2C tumor suppressor, guanylin, is universally lost in colorectal cancer.” Cancer Epidemiol Biomarkers Prev 23, no. 11 (November 2014): 2328–37. https://doi.org/10.1158/1055-9965.EPI-14-0440.
       Full Text  Link to Item
    • Chen, Y., A. J. Kovatich, J. L. Fantacone-Campbell, J. A. Hooke, L. Kvecher, A. W. Kovatich, C. M. Gallagher, et al. “Abstract P4-06-09: HER2+ and HER2- luminal B subtypes have similar overall survival and histologic grade distributions.” Poster Session Abstracts, December 15, 2013. https://doi.org/10.1158/0008-5472.sabcs13-p4-06-09.
       Full Text
    • Girondo, M. A., A. R. Peck, B. Freydin, I. Chervoneva, T. Hyslop, A. J. Kovatich, J. A. Hooke, C. D. Shriver, E. P. Mitchell, and H. Rui. “Abstract P1-08-20: Increased risk of hormone therapy failure in breast cancers expressing low phospho-Stat5: Validation of quantitative immunofluorescence assay parameters.” Poster Session Abstracts, December 15, 2013. https://doi.org/10.1158/0008-5472.sabcs13-p1-08-20.
       Full Text
    • Kovatich, A. J., Y. Chen, J. L. Fantacone-Campbell, J. A. Wareham, L. Tafra, L. Kvecher, T. Hyslop, et al. “Abstract P4-06-03: Assays on core biopsies and surgically resected tumors may result in different subtyping of the invasive breast cancer from the same patient.” Poster Session Abstracts, December 15, 2013. https://doi.org/10.1158/0008-5472.sabcs13-p4-06-03.
       Full Text
    • Hyslop, Terry, Yvonne Michael, Tiffany Avery, and Hallgeir Rui. “Population and target considerations for triple-negative breast cancer clinical trials.” Biomark Med 7, no. 1 (February 2013): 11–21. https://doi.org/10.2217/bmm.12.114.
       Full Text  Link to Item
    • Lin, Jieru Egeria, Adam Eugene Snook, Peng Li, Brian Arthur Stoecker, Gilbert Won Kim, Michael Sullivan Magee, Alex Vladimir Mejia Garcia, et al. “GUCY2C opposes systemic genotoxic tumorigenesis by regulating AKT-dependent intestinal barrier integrity.” Plos One 7, no. 2 (2012): e31686. https://doi.org/10.1371/journal.pone.0031686.
       Full Text  Link to Item
    • Peck, A. R., A. K. Witkiewicz, C. Liu, A. C. Klimowicz, G. A. Stringer, E. Pequignot, B. Freydin, et al. “P1-06-24: Nuclear Localization of Stat5a Predicts Response to Antiestrogen Therapy and Prognosis of Clinical Breast Cancer Outcome.” Poster Session Abstracts, December 15, 2011. https://doi.org/10.1158/0008-5472.sabcs11-p1-06-24.
       Full Text
    • Peck, Amy R., Agnieszka K. Witkiewicz, Chengbao Liu, Ginger A. Stringer, Alexander C. Klimowicz, Edward Pequignot, Boris Freydin, et al. “Loss of nuclear localized and tyrosine phosphorylated Stat5 in breast cancer predicts poor clinical outcome and increased risk of antiestrogen therapy failure.” J Clin Oncol 29, no. 18 (June 20, 2011): 2448–58. https://doi.org/10.1200/JCO.2010.30.3552.
       Full Text  Link to Item
    • Peck, Amy R., Agnieszka K. Witkiewicz, Chengbao Liu, Ginger A. Stringer, Alexander C. Klimowicz, Edward Pequignot, Boris Freydin, et al. “Abstract 2277: Loss of nuclear localized and tyrosine phosphorylated Stat5: A predictor of poor clinical outcome and increased risk of antiestrogen therapy failure in breast cancer.” Clinical Research, April 15, 2011. https://doi.org/10.1158/1538-7445.am2011-2277.
       Full Text
    • Chervoneva, Inna, Yanyan Li, Stephanie Schulz, Sean Croker, Chantell Wilson, Scott A. Waldman, and Terry Hyslop. “Selection of optimal reference genes for normalization in quantitative RT-PCR.” Bmc Bioinformatics 11 (May 14, 2010): 253. https://doi.org/10.1186/1471-2105-11-253.
       Full Text  Link to Item
    • Waldron, Todd J., Angele R. Soliera, Ying Zhang, Robert Martinez, Terry Hyslop, Timothy Bender, and Bruno Calabretta. “Abstract 5061: Induction of B cell acute lymphoblastic leukemia by BCR/ABL requires c-Myb and its activation of Bmi-1.” Cellular and Molecular Biology, April 15, 2010. https://doi.org/10.1158/1538-7445.am10-5061.
       Full Text
    • Lin, Jieru Egeria, Peng Li, Adam Eugene Snook, Stephanie Schulz, Abhijit Dasgupta, Terry Marie Hyslop, Ahmara Vivian Gibbons, Glen Marszlowicz, Giovanni Mario Pitari, and Scott Arthur Waldman. “The hormone receptor GUCY2C suppresses intestinal tumor formation by inhibiting AKT signaling.” Gastroenterology 138, no. 1 (January 2010): 241–54. https://doi.org/10.1053/j.gastro.2009.08.064.
       Full Text  Link to Item
    • Waldman, Scott A., Terry Hyslop, Stephanie Schulz, Alan Barkun, Karl Nielsen, Janis Haaf, Christine Bonaccorso, Yanyan Li, and David S. Weinberg. “Association of GUCY2C expression in lymph nodes with time to recurrence and disease-free survival in pN0 colorectal cancer.” Jama 301, no. 7 (February 18, 2009): 745–52. https://doi.org/10.1001/jama.2009.141.
       Full Text  Link to Item
    • Yu, Zuoren, Chenguang Wang, Min Wang, Zhiping Li, Mathew C. Casimiro, Manran Liu, Kongming Wu, et al. “A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation.” J Cell Biol 182, no. 3 (August 11, 2008): 509–17. https://doi.org/10.1083/jcb.200801079.
       Full Text  Link to Item
    • Waldman, S. A., T. Hyslop, S. Schulz, K. Nielsen, J. Haaf, C. Bonaccorso, Y. Li, A. Barkun, and D. Weinberg. “A prospective multicenter study of guanylyl cyclase C (GCC), quantified by the reverse transcriptase-polymerase chain reaction (qRT-PCR), as a prognostic marker of occult metastases in lymph nodes of pN0 colorectal cancer patients.” J Clin Oncol 26, no. 15_suppl (May 20, 2008): 11011.
       Link to Item
    • Witkiewicz, A., A. Ryder, L. M. Neilson, F. E. Utama, T. H. Tran, T. Hyslop, and H. Rui. “Transcription factors Stat5a and Stat5b: Favorable prognostic markers in breast cancer.” J Clin Oncol 26, no. 15_suppl (May 20, 2008): 22071.
       Link to Item
    • Chervoneva, Inna, Yanyan Li, Boris Iglewicz, Scott Waldman, and Terry Hyslop. “Relative quantification based on logistic models for individual polymerase chain reactions.” Stat Med 26, no. 30 (December 30, 2007): 5596–5611. https://doi.org/10.1002/sim.3127.
       Full Text  Link to Item
    • Calin, George A., Chang-gong Liu, Manuela Ferracin, Terry Hyslop, Riccardo Spizzo, Cinzia Sevignani, Muller Fabbri, et al. “Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas.” Cancer Cell 12, no. 3 (September 2007): 215–29. https://doi.org/10.1016/j.ccr.2007.07.027.
       Full Text  Link to Item
    • Chervoneva, Inna, Boris Iglewicz, and Terry Hyslop. “A general approach for two-stage analysis of multilevel clustered non-Gaussian data.” Biometrics 62, no. 3 (September 2006): 752–59. https://doi.org/10.1111/j.1541-0420.2005.00512.x.
       Full Text  Link to Item
    • Calin, George Adrian, Cinzia Sevignani, Calin Dan Dumitru, Terry Hyslop, Evan Noch, Sai Yendamuri, Masayoshi Shimizu, et al. “Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers.” Proc Natl Acad Sci U S A 101, no. 9 (March 2, 2004): 2999–3004. https://doi.org/10.1073/pnas.0307323101.
       Full Text  Link to Item
    • Ober, C., T. Hyslop, S. Elias, L. R. Weitkamp, and W. W. Hauck. “Human leukocyte antigen matching and fetal loss: results of a 10 year prospective study.” Hum Reprod 13, no. 1 (January 1998): 33–38. https://doi.org/10.1093/humrep/13.1.33.
       Full Text  Link to Item

  • Conference Papers

    • Shah, Anand, Thomas J. Polascik, Daniel J. George, John Anderson, Terry Hyslop, Alicia M. Ellis, Andrew J. Armstrong, et al. “Implementation and Impact of a Risk-Stratified Prostate Cancer Screening Algorithm as a Clinical Decision Support Tool in a Primary Care Network.” In J Gen Intern Med, 36:92–99, 2021. https://doi.org/10.1007/s11606-020-06124-2.
       Full Text  Link to Item
    • Larsen, Alexandra, Viktoria Kolpacoff, Kara McCormack, and Terry Hyslop. “Latent class analysis of multipollutant exposure.” In Cancer Prevention Research, 13:28–28, 2020.
       Link to Item
    • Magbanua, Mark Jesus M., Wen Li, Denise M. Wolf, Christina Yau, Gillian L. Hirst, Lamorna Brown-Swigart, A Jo Chien, et al. “Abstract A50: Circulating tumor DNA (ctDNA) and magnetic resonance imaging (MRI) for monitoring and predicting response to neoadjuvant therapy (NAT) in high-risk early breast cancer patients in the I-SPY 2 TRIAL.” In Poster Presentations  Proffered Abstracts. American Association for Cancer Research, 2020. https://doi.org/10.1158/1557-3265.liqbiop20-a50.
       Full Text
    • Hoadley, Katherine A., Bradford C. Powell, Dona Kanavy, David Marron, Lisle E. Mose, Terry Hyslop, Donald A. Berry, et al. “Abstract P4-05-03: Mutational analysis of triple-negative breast cancer (TNBC): CALGB 40603 (Alliance).” In Poster Session Abstracts. American Association for Cancer Research, 2020. https://doi.org/10.1158/1538-7445.sabcs19-p4-05-03.
       Full Text
    • Rosenberg, Shoshana M., Laura H. Hendrix, Kristin L. Schreiber, Alastair M. Thompson, Isabelle Bedrosian, Kevin S. Hughes, Thomas Lynch, et al. “Abstract P1-21-07: The Patient-reported Outcomes after Routine Treatment of Atypical Lesions (PORTAL) study: Pain, psychosocial wellbeing, and quality of life among women undergoing guideline concordant care for DCIS vs. active surveillance for in situ and atypical lesions.” In Poster Session Abstracts. American Association for Cancer Research, 2020. https://doi.org/10.1158/1538-7445.sabcs19-p1-21-07.
       Full Text
    • Sammons, Sarah, Yi Ren, Jeremy Force, Oluwadamilola M. Fayanju, Laura H. Rosenberger, Jennifer K. Plichta, Gretchen Kimmick, et al. “Abstract P3-08-10: Characterization of oncotype DX recurrence score and chemotherapy utilization patterns in young women (≤40) with early stage ER+/HER-, lymph node negative breast cancer.” In Poster Session Abstracts. American Association for Cancer Research, 2020. https://doi.org/10.1158/1538-7445.sabcs19-p3-08-10.
       Full Text
    • Satpathy, Shankha, Eric Jaehnig, Krug Karsten, Beom-Jun Kim, Alexander Saltzman, Doug Chan, Kimberly Holloway, et al. “Abstract GS2-05: Microscaled proteogenomic methods for precision oncology.” In General Session Abstracts. American Association for Cancer Research, 2020. https://doi.org/10.1158/1538-7445.sabcs19-gs2-05.
       Full Text
    • Lowe, Jared, Jessica Beliveau, Kearston Ingraham, Samantha Thomas, Terry Hyslop, Karen Steinhauser, David Casarett, and Nadine Barrett. “Project PLACE (Population Level Approaches to Cancer Elimination): Perceptions of Palliative Care Across Diverse Communities.” In Journal of Pain and Symptom Management, 59:541–42. ELSEVIER SCIENCE INC, 2020.
       Link to Item
    • Plichta, Jennifer K., Samantha M. Thomas, Rebecca Vernon, Oluwadamilola M. Fayanju, Laura H. Rosenberger, Terry Hyslop, E Shelley Hwang, and Rachel A. Greenup. “Breast cancer tumor histopathology, stage at presentation, and treatment in the extremes of age.” In Breast Cancer Res Treat, 180:227–35, 2020. https://doi.org/10.1007/s10549-020-05542-4.
       Full Text  Link to Item
    • Greenup, Rachel A., Christel N. Rushing, Laura J. Fish, Whitney O. Lane, Jeffrey M. Peppercorn, Emily Bellavance, Lisa Tolnitch, et al. “Perspectives on the Costs of Cancer Care: A Survey of the American Society of Breast Surgeons.” In Ann Surg Oncol, 26:3141–51, 2019. https://doi.org/10.1245/s10434-019-07594-3.
       Full Text  Link to Item
    • Rosenberger, Laura H., Samantha M. Thomas, Jennifer K. Plichta, Oluwadamilola M. Fayanju, Terry Hyslop, Rachel A. Greenup, and E Shelley Hwang. “Decreasing rates of axillary lymph node dissections over time: Implications for surgical resident exposure and operative skills development.” In Am J Surg, 218:786–91, 2019. https://doi.org/10.1016/j.amjsurg.2019.07.013.
       Full Text  Link to Item
    • Thornton, M. J., H. V. Williamson, K. E. Westbrook, R. A. Greenup, J. K. Plichta, L. H. Rosenberger, A. M. Gupta, T. Hyslop, E. S. Hwang, and O. M. Fayanju. “Neoadjuvant Endocrine Therapy Versus Neoadjuvant Chemotherapy in Node-Positive Invasive Lobular Carcinoma.” In Ann Surg Oncol, 26:3166–77, 2019. https://doi.org/10.1245/s10434-019-07564-9.
       Full Text  Link to Item
    • Zambeli-Ljepovic, Alan, Frances Wang, Michaela A. Dinan, Terry Hyslop, Michael T. Stang, Sanziana A. Roman, Julie Ann Sosa, and Randall P. Scheri. “Low Risk Thyroid Cancer in Older Adults: More Extensive Surgery Comes with Increased Cost of Surveillance.” In Journal of the American College of Surgeons, 229:S78–S78. ELSEVIER SCIENCE INC, 2019.
       Link to Item
    • Varga, M. G., J. Butt, W. J. Blot, L. Le Marchand, C. Haiman, Y. Chen, S. Wassertheil-Smoller, et al. “Racial differences in Helicobacter pylori antibody prevalence by year of birth and demographic factors in a consortium of US adults.” In Helicobacter, Vol. 24. WILEY, 2019.
       Link to Item
    • Turner, Megan C., Jeffrey E. Keenan, Christel N. Rushing, Brian C. Gulack, Daniel P. Nussbaum, Ehsan Benrashid, Terry Hyslop, John H. Strickler, Christopher R. Mantyh, and John Migaly. “Adjuvant Chemotherapy Improves Survival Following Resection of Locally Advanced Rectal Cancer with Pathologic Complete Response.” In J Gastrointest Surg, 23:1614–22, 2019. https://doi.org/10.1007/s11605-018-04079-8.
       Full Text  Link to Item
    • Varga, Matthew G., Julia Butt, William Blot, Loic La Marchand, Chris Haiman, Yu Chen, Sylvia Wassertheil-Smoller, et al. “HELICOBACTER PYLORI ANTIBODY PREVALENCE BY YEAR OF BIRTH AND DEMOGRAPHIC FACTORS IN A CONSORTIUM OF US ADULTS.” In Gastroenterology, 156:S523–24. W B SAUNDERS CO-ELSEVIER INC, 2019.
       Link to Item
    • Varga, Matthew G., Laura Hendrix, William Blot, Julia Butt, Howard D. Sesso, Richard M. Peek, John D. Potter, et al. “HELICOBACTER PYLORI INFECTION DOES NOT MODIFY THE PROTECTIVE EFFECT OF REGULAR ASPIRIN USE ON COLORECTAL CANCER RISK IN A POPULATION OF US ADULTS.” In Gastroenterology, 156:S821–22. W B SAUNDERS CO-ELSEVIER INC, 2019.
       Link to Item
    • Mremi, Alex, Gloria Broadwater, Terry Hyslop, and Allison Hall. “Breast Cancer in Tanzanian Patients: An Assessment of Tumor Type, Grade, Biomarker status, and Tumor Infiltrating Lymphocytes.” In Laboratory Investigation, Vol. 99. NATURE PUBLISHING GROUP, 2019.
       Link to Item
    • Mremi, Alex, Gloria Broadwater, Terry Hyslop, and Allison Hall. “Breast Cancer in Tanzanian Patients: An Assessment of Tumor Type, Grade, Biomarker status, and Tumor Infiltrating Lymphocytes.” In Modern Pathology, Vol. 32. NATURE PUBLISHING GROUP, 2019.
       Link to Item
    • Crosby, E. J., W. R. Gwin, S. Chang, H. T. Maecker, V. Lubkov, J. C. Snyder, G. Broadwater, et al. “Abstract P2-09-16: CD8 T cells induced by novel alphaviral vector predict improved progression free survival in advanced HER2+ breast cancer patients.” In Poster Session Abstracts. American Association for Cancer Research, 2019. https://doi.org/10.1158/1538-7445.sabcs18-p2-09-16.
       Full Text
    • Force, J., J. Plichta, I. Stashko, G. Kimmick, K. Westbrook, S. Sammons, S. Hwang, et al. “Abstract P3-08-07: Distinct biological signatures describe differences in BRCA mutated subgroups.” In Poster Session Abstracts. American Association for Cancer Research, 2019. https://doi.org/10.1158/1538-7445.sabcs18-p3-08-07.
       Full Text
    • Butt, Julia, Matthew G. Varga, William J. Blot, Lauren Teras, Kala Visvanathan, Loïc Le Marchand, Christopher Haiman, et al. “Serologic Response to Helicobacter pylori Proteins Associated With Risk of Colorectal Cancer Among Diverse Populations in the United States.” In Gastroenterology, 156:175-186.e2, 2019. https://doi.org/10.1053/j.gastro.2018.09.054.
       Full Text  Link to Item
    • Greenup, Rachel A., Christel Rushing, Laura Fish, Brittany M. Campbell, Lisa Tolnitch, Terry Hyslop, Jeffrey Peppercorn, et al. “Financial Burden Related to Decisions for Breast Cancer Surgery.” In Journal of Womens Health, 27:1422–23. MARY ANN LIEBERT, INC, 2018.
       Link to Item
    • Greenup, Rachel Adams, Christel Rushing, Laura Fish, Terry Hyslop, Jeffrey M. Peppercorn, Stephanie B. Wheeler, Yousuf Zafar, Evan Myers, and Eun-Sil Shelley Hwang. “The costs of breast cancer care: Patient-reported experiences and preferences for transparency.” In Journal of Clinical Oncology, 36:207–207. American Society of Clinical Oncology (ASCO), 2018. https://doi.org/10.1200/jco.2018.36.30_suppl.207.
       Full Text
    • Tamirisa, Nina, Samantha M. Thomas, Oluwadamilola M. Fayanju, Rachel A. Greenup, Laura H. Rosenberger, Terry Hyslop, E Shelley Hwang, and Jennifer K. Plichta. “Axillary Nodal Evaluation in Elderly Breast Cancer Patients: Potential Effects on Treatment Decisions and Survival.” In Ann Surg Oncol, 25:2890–98, 2018. https://doi.org/10.1245/s10434-018-6595-2.
       Full Text  Link to Item
    • Zambeli-Ljepovic, Alan, Frances Wang, Terry Hyslop, Sanziana A. Roman, Julie A. Sosa, and Randall P. Scheri. “Total Thyroidectomy and Radioactive Iodine for Elderly Patients with Low-Risk Papillary Thyroid Cancer Confers No Survival Benefit over Lobectomy Alone.” In Journal of the American College of Surgeons, 227:S88–89. Ovid Technologies (Wolters Kluwer Health), 2018. https://doi.org/10.1016/j.jamcollsurg.2018.07.176.
       Full Text
    • Lane, Whitney, Samantha Thomas, Jennifer Plichta, Laura Rosenberger, Oluwadamilola Fayanju, Terry Hyslop, E Shelley Hwang, and Rachel Greenup. “Extent of axillary surgery in women with Stage IV breast cancer.” In Annals of Surgical Oncology, 25:291–92. SPRINGER, 2018.
       Link to Item
    • Force, Jeremy Meyer, Sarah Abbott, Gloria Broadwater, Ilona Stashko, Kelly E. Westbrook, Gretchen Genevieve Kimmick, Sarah LeNoir Sammons, et al. “Immune profiling of BRCA-mutated breast cancers.” In Journal of Clinical Oncology, 36:585–585. American Society of Clinical Oncology (ASCO), 2018. https://doi.org/10.1200/jco.2018.36.15_suppl.585.
       Full Text
    • Plichta, Jennifer Kay, Samantha M. Thomas, Amanda R. Sergesketter, Oluwadamilola Motunrayo Fayanju, Rachel Adams Greenup, Laura Horst Rosenberger, Gretchen Genevieve Kimmick, Terry Hyslop, and Eun-Sil Shelley Hwang. “Restaging de novo metastatic breast cancer to refine prognostic estimates.” In Journal of Clinical Oncology, 36:e13083–e13083. American Society of Clinical Oncology (ASCO), 2018. https://doi.org/10.1200/jco.2018.36.15_suppl.e13083.
       Full Text
    • Tamirisa, Nina Prabha, Hannah Vernia, Samantha M. Thomas, Kelly E. Westbrook, Rachel Adams Greenup, Jennifer Kay Plichta, Laura Horst Rosenberger, Terry Hyslop, Eun-Sil Shelley Hwang, and Oluwadamilola Motunrayo Fayanju. “The impact of chemotherapy sequence on survival in node-positive invasive lobular carcinoma.” In Journal of Clinical Oncology, 36:587–587. American Society of Clinical Oncology (ASCO), 2018. https://doi.org/10.1200/jco.2018.36.15_suppl.587.
       Full Text
    • Sullivan, Brian, Thomas S. Redding, Elizabeth R. Hauser, Ziad F. Gellad, Xuejun Qin, Samir Gupta, Douglas J. Robertson, et al. “HIGH RISK ADENOMAS AT BASELINE COLONOSCOPY ASSOCIATED WITH FUTURE ADVANCED ADENOMA DESPITE AN INTERVENING NEGATIVE COLONOSCOPY.” In Gastroenterology, 154:S29–S29. W B SAUNDERS CO-ELSEVIER INC, 2018.
       Link to Item
    • Greenup, R. A., C. N. Rushing, L. J. Fish, B. Campbell, T. Hyslop, J. M. Peppercorn, E. R. Myers, Y. Zafar, and E. S. Hwang. “Breast Cancer Treatment Costs: Surgical Decisions and Preferences for Transparency.” In Annals of Surgical Oncology, 25:S15–S15. SPRINGER, 2018.
       Link to Item
    • Hwang, E Shelley, Stephanie Duong, Isabelle Bedrosian, Jacob Allred, Dorota Wisner, Terry Hyslop, Abigail Caudle, et al. “Primary endocrine therapy for ER-positive ductal carcinoma in situ (DCIS) CALGB 40903 (Alliance).” In Cancer Research, Vol. 78. AMER ASSOC CANCER RESEARCH, 2018.
       Link to Item
    • Magbanua, Mark J., Laura Hendrix, Terry Hyslop, William T. Barry, Eric P. Winer, Clifford Hudis, Deborah Toppmeyer, et al. “Trajectory patterns of circulating tumor cells (CTC) in chemotherapy-treated metastatic breast cancer (MBC) patients predict poor clinical outcomes: CALGB 40502 (Alliance)/NCCTG N063H study.” In Cancer Research, Vol. 78. AMER ASSOC CANCER RESEARCH, 2018.
       Link to Item
    • Oyekunle, Taofik O., Samantha M. Thomas, Rachel A. Greenup, Terry Hyslop, and Kimberly Blackwell. “Incidence and mortality among breast cancer patients < 40 years old: US trends from 1992-2014.” In Cancer Research, Vol. 78. AMER ASSOC CANCER RESEARCH, 2018.
       Link to Item
    • Plichta, J. K., S. M. Thomas, R. A. Greenup, O. M. Fayanju, L. H. Rosenberger, N. Tamirisa, T. Hyslop, and E. S. Hwang. “Clinical and Pathologic Stage Discordance is Associated with Breast Cancer Prognosis.” In Annals of Surgical Oncology, 25:S94–S94. SPRINGER, 2018.
       Link to Item
    • Ryser, Marc D., Donald L. Weaver, Jeffrey R. Marks, Terry Hyslop, and E Shelley Hwang. “Quantifying the natural history and overtreatment rate of ductal carcinoma in situ.” In Cancer Research, Vol. 78. AMER ASSOC CANCER RESEARCH, 2018.
       Link to Item
    • Thomas, S. M., O. M. Fayanju, J. K. Plichta, L. H. Rosenberger, J. Force, T. Hyslop, E. S. Hwang, and R. A. Greenup. “Treatment Patterns and Outcomes for Breast Cancer with Isolated Supraclavicular Metastases.” In Annals of Surgical Oncology, 25:S26–S26. SPRINGER, 2018.
       Link to Item
    • Hong, Julian C., Elizabeth Hauser, Thomas S. Redding, Kellie Sims, Ziad Gellad, Meghan O’Leary, Terry Hyslop, et al. “Network analysis of chronological relationships of comorbidities in veterans from a prospective screening colonoscopy trial.” In Amia. AMIA, 2018.
    • Greenup, Rachel Adams, Laura Fish, Christel Rushing, Jeffrey Peppercorn, Terry Hyslop, Yousuf Zafar, and E Shelley Hwang. “The Financial Burden of Breast Cancer Treatment.” In Journal of Womens Health, 26:1022–1022. MARY ANN LIEBERT, INC, 2017.
       Link to Item
    • Campbell, Brittany Morgan, Samantha Marie Thomas, Cecilia Tuongquang Ong, Rachel Adams Greenup, Jennifer Kay Plichta, Laura Horst Rosenberger, Jeremy Meyer Force, Terry Hyslop, Eun-Sil Shelley Hwang, and Oluwadamilola Motunrayo Fayanju. “The epidemiology of metaplastic breast cancer: A review of 2,500 cases from the national cancer database.” In Journal of Clinical Oncology, 35:1570–1570. American Society of Clinical Oncology (ASCO), 2017. https://doi.org/10.1200/jco.2017.35.15_suppl.1570.
       Full Text
    • Greenup, Rachel Adams, Samantha Marie Thomas, Oluwadamilola Motunrayo Fayanju, Terry Hyslop, and Eun-Sil Shelley Hwang. “Impact of insurance status on treatment for stage 0-IV breast cancer.” In Journal of Clinical Oncology, 35:6532–6532. American Society of Clinical Oncology (ASCO), 2017. https://doi.org/10.1200/jco.2017.35.15_suppl.6532.
       Full Text
    • Martin, Miguel, Sibylle Loibl, Terry Hyslop, Juan de la Haba-Rodriguez, Bahriye Aktas, Constance Cirrincione, Eva Maria Carrasco, et al. “Evaluating the addition of bevacizumab (Bev) to endocrine therapy as first-line treatment for hormone-receptor positive (HR+)/HER2-negative advanced breast cancer (ABC): Pooled-analysis from the LEA (GEICAM/2006-11_GBG51) and CALGB 40503 (Alliance) trials.” In Journal of Clinical Oncology, 35:1012–1012. American Society of Clinical Oncology (ASCO), 2017. https://doi.org/10.1200/jco.2017.35.15_suppl.1012.
       Full Text
    • Musselwhite, Laura W., Thomas S. Redding, Kellie J. Sims, Meghan O’Leary, Elizabeth R. Hauser, Terry Hyslop, David A. Lieberman, and Dawn T. Provenzale. “Validation of the NCI colorectal cancer risk assessment tool in the CSP 380 veterans cohort.” In Journal of Clinical Oncology, 35:e15135–e15135. American Society of Clinical Oncology (ASCO), 2017. https://doi.org/10.1200/jco.2017.35.15_suppl.e15135.
       Full Text
    • Narloch, Jessie, Catherine Luedke, Gloria Broadwater, Nolan Priedigkeit, Allison Hall, Terry Hyslop, Sarah LeNoir Sammons, et al. “Number of tumor-infiltrating lymphocytes in breast cancer brain metastases compared to matched breast primaries.” In Journal of Clinical Oncology, 35:2049–2049. American Society of Clinical Oncology (ASCO), 2017. https://doi.org/10.1200/jco.2017.35.15_suppl.2049.
       Full Text
    • Ong, Cecilia Tuongquang, Samantha Marie Thomas, Brittany Morgan Campbell, Rachel Adams Greenup, Jennifer Kay Plichta, Laura Horst Rosenberger, Jeremy Meyer Force, Terry Hyslop, Eun-Sil Shelley Hwang, and Oluwadamilola Motunrayo Fayanju. “A population-based analysis of treatment and outcomes in 2,500 metaplastic breast cancer patients.” In Journal of Clinical Oncology, 35:532–532. American Society of Clinical Oncology (ASCO), 2017. https://doi.org/10.1200/jco.2017.35.15_suppl.532.
       Full Text
    • Plichta, Jennifer Kay, Samantha Marie Thomas, Oluwadamilola Motunrayo Fayanju, Laura Horst Rosenberger, Tristen Sinae Park, Terry Hyslop, Rachel Adams Greenup, and Eun-Sil Shelley Hwang. “Temporal associations between prognostic indicators and overall survival after breast cancer.” In Journal of Clinical Oncology, 35:e18144–e18144. American Society of Clinical Oncology (ASCO), 2017. https://doi.org/10.1200/jco.2017.35.15_suppl.e18144.
       Full Text
    • Lane, Whitney, Samantha M. Thomas, Jennifer K. Plichta, Oluwadamilola M. Fayanju, Laura H. Rosenberger, Terry Hyslop, E Shelley Hwang, and Rachel A. Greenup. “Surgical resection of the primary tumor in women with stage IV breast cancer: Contemporary practice patterns and survival analysis.” In Annals of Surgical Oncology, 24:46–46. SPRINGER, 2017.
       Link to Item
    • Ong, Cecilia, Samantha Thomas, Laura Rosenberger, Tristen Park, Jennifer Plichta, Oluwadamilola Fayanju, Terry Hyslop, E Shelley Hwang, and Rachel Greenup. “Patient age and tumor subtype predicts adherence to ACOSOG Z0011 recommendations: Analysis of national practice patterns.” In Annals of Surgical Oncology, 24:164–65. SPRINGER, 2017.
       Link to Item
    • Park, Tristen, Samantha Thomas, Laura Rosenberger, Oluwadamilola Fayanju, Jennifer Plichta, Cecilia Ong, Terry Hyslop, E Shelley Hwang, and Rachel Greenup. “The Impact of Axillary Surgery on Women with N2-N3 Invasive Breast Cancer.” In Annals of Surgical Oncology, 24:162–63. SPRINGER, 2017.
       Link to Item
    • Force, J., S. Abbott, G. Broadwater, G. Kimmick, K. Westbrook, S. Hwang, N. Kauff, et al. “Abstract P2-04-19: Elucidating the tumor immune microenvironment phenotype in early stage untreated BRCA mutated breast cancer patients.” In Poster Session Abstracts. American Association for Cancer Research, 2017. https://doi.org/10.1158/1538-7445.sabcs16-p2-04-19.
       Full Text
    • Hoadley, K. A., T. Hyslop, C. Fan, D. A. Berry, O. Hahn, S. M. Tolaney, W. M. Sikov, C. M. Perou, and L. A. Carey. “Abstract PD1-03: Multivariate analysis of subtype and gene expression signatures predictive of pathologic complete response (pCR) in triple-negative breast cancer (TNBC): CALGB 40603 (Alliance).” In Poster Discussion Abstracts. American Association for Cancer Research, 2017. https://doi.org/10.1158/1538-7445.sabcs16-pd1-03.
       Full Text
    • Narloch, J. L., K. Harnden, G. Broadwater, B. Peterson, T. Hyslop, J. Kirkpatrick, P. Fecci, G. Kim, and K. L. Blackwell. “Abstract P5-08-12: HER2 status remains the primary predictor of improved survival in patients with BCBM over the past 2 decades (1996-2015).” In Poster Session Abstracts. American Association for Cancer Research, 2017. https://doi.org/10.1158/1538-7445.sabcs16-p5-08-12.
       Full Text
    • Tanioka, M., C. Fan, L. A. Carey, T. Hyslop, B. N. Pitcher, J. A. Parker, K. A. Hoadley, et al. “Abstract S3-05: Integrated analysis of multidimensional genomic data on CALGB 40601 (Alliance), a randomized neoadjuvant phase III trial of weekly paclitaxel (T) and trastuzumab (H) with or without lapatinib (L) for HER2-positive breast cancer.” In General Session Abstracts. American Association for Cancer Research, 2017. https://doi.org/10.1158/1538-7445.sabcs16-s3-05.
       Full Text
    • Freedman, Jennifer, Yanru Wang, Hongliang Liu, Patricia Moorman, Terry Hyslop, Daniel George, Norman Lee, Qingyi Wei, and Steven Patierno. “Abstract B58: Single-nucleotide polymorphisms of race-related alternatively spliced genes associate with prostate cancer risk, aggressiveness and/or survival.” In Epidemiology, Lifestyle, and Genetics. American Association for Cancer Research, 2017. https://doi.org/10.1158/1538-7755.disp16-b58.
       Full Text
    • Kim, Edward, Michaela Dinan, KM Monirul Islam, Ancilla Fernandes, Lee Schwartzberg, Elisabeth Croft, Julie Brahmer, et al. “Registry for the EVolution Of LUng Cancer Therapy Implementation and Outcomes Now (REVOLUTION): Registry Study in Progress.” In Journal of Thoracic Oncology, 11:S308–9. ELSEVIER SCIENCE INC, 2016.
       Link to Item
    • Hwang, E Shelley, Tracie D. Locklear, Christel N. Rushing, Greg Samsa, Amy P. Abernethy, Terry Hyslop, and Dunya M. Atisha. “Patient-Reported Outcomes After Choice for Contralateral Prophylactic Mastectomy.” In J Clin Oncol, 34:1518–27, 2016. https://doi.org/10.1200/JCO.2015.61.5427.
       Full Text  Link to Item
    • Hyslop, T., M. Alvarado, A. Forero, M. Golshan, T. Hieken, J. Horton, C. Hudis, et al. “Abstract S3-06: Treatment outcomes in patients with invasive breast cancer treated with neoadjuvant systemic therapy and breast MR imaging: Results of a secondary analysis of TBCRC 017.” In General Session Abstracts. American Association for Cancer Research, 2016. https://doi.org/10.1158/1538-7445.sabcs15-s3-06.
       Full Text
    • Palumbo, Aimee, Yvonne Michael, and Terry Hyslop. “Abstract 4137: Latent class model characterization of neighborhood SES.” In Epidemiology. American Association for Cancer Research, 2014. https://doi.org/10.1158/1538-7445.am2014-4137.
       Full Text
    • Eberhardt, J. S., T. Hyslop, E. Mitchell, H. Hu, and H. Rui. “Bayesian Belief Network Mortality Analysis of a Breast Cancer Registry Data Set.” In Cancer Research, Vol. 71. AMER ASSOC CANCER RESEARCH, 2011. https://doi.org/10.1158/0008-5472.5ABCS11-P5-14-12.
       Full Text  Link to Item
    • Weinberg, David, Terry Hyslop, Alan N. Barkun, Stephanie Schulz, and Scott A. Waldman. “GUCY2C Analysis Accurately Stratifies Risk for Recurrence in Early Stage CRC.” In Gastroenterology, 138:S18–19. W B SAUNDERS CO-ELSEVIER INC, 2010.
       Link to Item
    • Witkiewicz, Agnieszka, Tran Thai, Ozlem Er, Terry Hyslop, and Hallgeir Rui. “Nuclear expression of transcription factors Stat5a and Stat5b confers favorable prognosis in breast cancer.” In Cancer Research, Vol. 69. AMER ASSOC CANCER RESEARCH, 2009.
       Link to Item

  • Datasets

    • Hall, Allison, Alex Mremi, Terry Hyslop, Patrick Amsi, Gloria Broadwater, Kahima Jackson, Cosmas Mbulwa, and Cecilia Ong. “Data from: Breast cancer in Tanzanian, black American, and white American women: An assessment of prognostic and predictive features, including tumor infiltrating lymphocytes,” October 2, 2019. https://doi.org/10.7924/r4bv7g09k.
       Data Access

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.